Target intelligence / Profile preview

Dengue virus pre-membrane protein (prM)

Target
prM
Molecular classification
Viral structural protein, Glycoprotein, Membrane-associated protein
01

Overview

The dengue virus pre-membrane protein (prM) is a 166-amino acid glycoprotein embedded in the viral membrane, which plays a crucial role during virus assembly and maturation[1][4]. In immature virions, prM forms heterodimers with the envelope (E) protein, protecting the fusion loop and preventing premature fusion with host membranes. As virions move through the acidic environments of the trans-Golgi network and exosomes, prM exposes its furin cleavage site, is proteolytically processed, and the “pr” peptide is released; the mature M protein remains as a transmembrane anchor for the E shell[1][3][4]. The conformational rearrangement of prM and E is essential for infectious particle formation. Targeting the prM-E maturation step is a rational therapeutic strategy, but antibodies against prM may enhance disease via antibody-dependent enhancement (ADE)[4].

Other names
pre-membrane proteinprM glycoproteinprM/M proteinpr peptide (cleaved form)
02

Mechanism of action

Preventing prM cleavage or interfering with prM-E interactions to block virion maturation and infectivity; inhibiting prM stem interactions

03

Biological functions

Virus assemblyVirion maturationPreventing premature membrane fusionShielding the fusion loop of envelope protein EGlycosylation site for immune evasion and viral stability
04

Disease associations

Infection (dengue fever, dengue hemorrhagic fever)Antibody-dependent enhancement (ADE) due to prM-targeted immune responses
05

Safety considerations

ADE risk due to non-neutralizing anti-prM antibodies increasing viral uptake by Fc-receptor mediated pathwaysPotential for unintended immune enhancement rather than protection
06

Interacting drugs

None clinically approved; theoretical and experimental compounds targeting prM-E interaction or prM cleavage
07

Biomarkers

prM protein expressionprM-specific antibodies for monitoring viral maturation and vaccine response

Beyond the preview

Go deeper on Dengue virus pre-membrane protein (prM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue virus pre-membrane protein (prM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call